The purpose of this retrospective, multicentre case series was to describe the outcome following surgery and/or radiation of spinal meningiomas and nerve sheath tumours (NSTs) based upon treatment modality, with a specific aim to evaluate the survival times and time to recurrence following treatment for each histopathological diagnosis. Our hypothesis was that the addition of radiation therapy modalities to treatment will yield longer time to recurrence of clinical signs and survival time. Thirty-four dogs met the inclusion criteria of histopathologically 
The purpose of this retrospective, multicentre case series was to describe the outcome following surgery and/or radiation of spinal meningiomas and nerve sheath tumours (NSTs) based upon treatment modality, with a specific aim to evaluate the survival times and time to recurrence following treatment for each histopathological diagnosis. Our hypothesis was that the extradural-extramedullary (ED-EM). [1] [2] [3] [4] Extramedullary spinal cord neoplasms have been previously described to account for 85% of all spinal cord neoplasms, with IM spinal cord neoplasms comprising the remaining 15%. 1 Cross-sectional imaging, such as magnetic resonance imaging (MRI) or CT/myelogram, allows for improved ability to identify these spinal cord neoplasms. 1, 4 Extramedullary spinal cord lesions may be primary or secondary.
The most common primary tumours are nerve sheath tumours (NSTs) and meningiomas. 2, 3 The most common metastatic lesions are lymphoma, mammary carcinoma and prostatic carcinoma. Osteosarcoma and hemangiosarcoma may also be present in the epidural space, as well as lipomatous tumours (benign, infiltrative and malignant). Non-neoplastic extramedullary spinal cord lesions include dural cysts. 2, [5] [6] [7] Spinal cord neoplasms most commonly present in large breed dogs older than 5 years. No sex predilection has been demonstrated.
Age can range from 5 months to 13 years. 3, 8 Boxers and Golden
Retrievers are the most common breeds previously reported to be diagnosed with meningiomas, with no specific breed predilection reported for spinal NSTs. 2, 3 Presenting clinical signs can range from pain as a solitary sign to lameness, paresis or even paralysis associated with the affected cord segment. Frequently these signs show lateralization. Duration of clinical signs may vary depending upon the location of the lesion and degree of compression. 2, 3, [9] [10] [11] [12] Nerve sheath tumours can lead to chronic pain and muscle wasting with less specific neurolocalization. 
| Diagnostics
All available imaging studies (initial and recheck scans) were reviewed by a single board-certified blinded radiologist (L.H.) for repeat interpretation. The original initial MRI radiologist evaluation was utilized for 2 dogs whose MRI scans were unavailable for repeat interpretation. The histopathologic diagnosis was recorded from the histopathology report. Tissue that was described as a soft tissue or spindle cell sarcoma with NST as the primary differential diagnosis on histopathology was categorized as NST.
| Surgery
Surgery was performed as marginal resection, cytoreduction and decompression or incisional biopsy. Surgical procedures varied from hemilaminectomy AE durotomy/durectomy or ventral slot at the spinal location identified to be affected on MRI. The lesions were primarily resected with gentle blunt dissection, using sharp dissection where needed for nerve root resection due to tumour involvement. When biopsy was described, an incisional biopsy was performed to procure a histopathological diagnosis prior to radiation therapy. All surgeries were performed by a board-certified surgeon or neurologist.
| Treatments
Within their respective histopathological diagnosis group, patients were subdivided into groups according to their initial treatment received: (1) surgery alone, (2) surgery followed by fractionated radia- V10% <18 Gy, with a max point dose of 21.9 Gy. Fractionated radiation therapy consisted of 20 daily treatments ranging from 2.5 to 2.7 Gy to equal 50 to 54 Gy total treatment dose. Radiation occurred within 30 days after surgical resection for all patients that received surgery followed by fractionated radiation.
Recurrence of clinical signs was defined as clinical improvement followed by worsening of clinical signs consistent with their previous diagnosis. Recurrence time was documented as the date that the clinical signs returned.
| Statistical analysis
Continuous variables were tested for normality using histograms, skewness, kurtosis and Shapiro-Wilk tests. Variables that were non-normally distributed were presented as median and range. Categorical variables were presented by frequency and percentages.
Kaplan-Meier methodology was used to calculate the median and 95% confidence interval (CI) for time to first recurrence and overall survival time. In addition, first recurrence times and overall survival times were associated with treatment types and histopathology diagnoses. Dogs were censored in the time to first recurrence if they had no recurrence at the last follow-up or at time of death or were lost to follow-up. Dogs were censored in the survival analysis, if they were alive at the last follow-up or were lost to follow-up. The endpoint of death due to any cause was chosen given extramedullary spinal tumours are aggressive and often lead to death or euthanasia.
Statistical significance was set at P < .05. Statistical analyses were performed using commercially available software. 1 
| RESULTS
Forty-two dogs were identified from the medical record search with histopathologically diagnosed extramedullary spinal cord tumours. Of these dogs, 18 were diagnosed with NSTs and 16 were meningiomas.
The remaining cases were nephroblastoma (2), histiocytic sarcoma (2), lymphoma (1), hemangiosarcoma (1), myxosarcoma (1) and adenocarcinoma (1), and were therefore excluded from our study. Our resultant population was 34 dogs that had a histopathological diagnosis of either meningioma or NST.
Of the 18 NST dogs, 8 were female spayed, 7 were male castrated and 3 were male intact. Of the 16 meningiomas dogs, 7 were female spayed and 9 were male castrated. The median age at diagnosis was 9.0 years (range: 2.0-13.9 years); 9.8 years for meningiomas (range: 6.0-13.9 years) and 7. Evaluation for pulmonary metastasis was available for 30 of 34 dogs. Two dogs had a thoracic CT scan which did not have evidence of pulmonary metastasis, and the remainder had thoracic radiographs which did not show any evidence of pulmonary metastasis. Eight patients also had abdominal ultrasounds; 1 dog was diagnosed with hepatic nodules and 1 dog was diagnosed with a hepatic adenoma, which were deemed to be unrelated to their spinal tumours.
Adjunctive therapy consisted of steroid therapy alone in 10 of the meningioma patients and 14 of the NST patients. Two meningioma patients were treated with steroids and hydroxyurea, one meningioma patient was treated with hydroxyurea alone, and one meningioma patient was treated with steroids and an undocumented chemotherapy agent.
All patients included in this study had a histopathological diagnosis of their extramedullary spinal cord tumour obtained either at the time of surgical removal/debulking or as an incisional biopsy (in the case of the 2 patients treated with SRT alone). Surgery reports were available for 32 of 34 patients. Of these, 22 of 32 (68.8%) were described by the surgeon as intradural/extramedullary lesions and 10 of 32 (32.3%) were described as extradural lesions. One intradural lesion was described to have IM invasion; the histopathological diagnosis for this tumour was a meningioma. All meningiomas (16 of 16, 100.0%) were classified as intradural at surgery. For NSTs, 10 of 17 (58.8%) were described as extradural and 6 of 15 (40.0%) were described as intradural at surgery.
Eleven of the 16 meningiomas (69.0%) were located in the cranial cervical region (C1-4 nerve roots) and 8 of 17 (47.0%) NSTs were located in the caudal cervical region (C5-T1 nerve roots). The remaining tumours were located sporadically throughout the thoracolumbar region.
Three meningioma patients (18.8%) were euthanized over a year after treatment for other reasons: one for mammary carcinoma with pulmonary nodules, one for osteosarcoma, and the third for an unrelated neoplastic disease (type unavailable). Survival times for these patients were 366, 988 and 555 days, respectively.
At the end of our study period, 3 dogs were still alive (2 meningiomas and 1 NST), 4 were lost to follow-up (all meningiomas) and one survived an additional 210 days, one was lost to follow-up, and the third dog was alive at 1271 days post-op. Two of the 16 meningioma dogs were treated with surgery followed by fractionated radiation; one had recurrence at 300 days and was euthanized when also diagnosed with mammary neoplasia 378 days after treatment, and the other was euthanized 458 days after treatment (Figures 2 and 3 ).
Of the 18 NSTs within our study, 13 dogs were treated with surgery alone as their initial treatment. One of these dogs was euthanized intra-operatively. Two of these dogs were euthanized or died within the first 3 months (32 and 63 days), presumably due to lack of Abbreviations: NST, nerve sheath tumour; SRT, stereotactic radiation therapy; LTFU, lost to follow-up.
followed by fractionated radiation, with recurrence noted at 150 and 255 days; surviving 171 and 497 days, respectively (Figures 2 and 3 ).
Thirteen dogs in this study received some variant of radiation therapy, 5 of which were meningioma cases and 8 were NST cases.
Two were meningioma cases that had surgery followed by fractionated radiation for their initial treatment and 3 were meningioma cases that had surgery alone as their initial treatment went on to receive SRT when they were diagnosed with recurrence. The remaining 
| DISCUSSION
The most effective treatment for most malignant tumours is wide surgical excision. This is unfortunately not possible when considering treatment of brain and spinal cord lesions, 2, 3, 9 where only a marginal excision is often achieved at best. Nonetheless, surgery remains the mainstay of treatment for spinal meningiomas and NSTs. 2, 3 Fractionated radiation has also been used as an adjunct to surgery 2 to achieve a longer survival time and time to disease recurrence with spinal tumours. SRT can treat gross disease effectively and largely spare surrounding tissue, having a rapid dose drop off from the targeted tumour tissue; however, the availability of SRT in veterinary medicine limits its use. 13, 14 One of the other benefits of SRT is the ability to complete radiation therapy in 3 treatments vs 15 to 20 treatments required with fractionated radiation.
We reported the outcome of variations of surgery and/or radiation for the treatment of spinal meningiomas and NSTs including surgery alone, surgery combined with SRT, surgery followed by fractionated radiation and SRT therapy alone. In our small sample populations where SRT was used for treatment of recurrence, we also documented additional survival time gained. Although we could not statistically compare all of these groups due to small patient In our study, surgery alone was the most common form of initial treatment for both tumour types (14 meningiomas, 13 NSTs), followed by surgery with fractionated radiation (2 meningiomas, 2 NSTs), SRT alone (2 cases, both NSTs) and one NST case that was treated with a combination of debulking surgery followed by SRT as the initial therapy.
The number of SRT patients in this study is also skewed by the direct availability for SRT therapy within both of our study locations. For all patients that received surgery followed by fractionated radiation, radiation occurred within 30 days after surgical resection and recovery.
Chemotherapy is not commonly used alone or in conjunction with surgery or radiation for spinal tumours, other than for lymphoma. 2 Chemotherapy was sporadically used in this study for Further studies with larger patient populations are needed to show whether there is a significant increase in overall survival time for dogs that are treated with SRT when there is recurrence, in particular, when compared with dogs that have surgery immediately followed by fractionated radiation. Our study findings suggest that it may be better to wait for recurrence and then treat with SRT, rather than immediately follow surgery with fractionated radiation, since cases that had fractionated radiation after surgery did not show a longer time to recurrence or a longer survival time compared with those that had surgery alone. SRT for recurrence, however, gained substantial survival time. Late effects of radiation may be seen 6 months to years following completion of radiation therapy. 15 The dogs that received radiation to the spinal cord in this study remained below the recommended dosage limits set by the American Association of Physicists in Medicine. 13 By using these constraints, one would expect secondary myelitis, a late effect of radiation, to be absent or minimalized. Dosage deliverance to the tissue vs the FIGURE 3 Kaplan-Meier curve to show recurrence probability in 34 dogs with spinal cord meningiomas and nerve sheath tumours by histopathology planned dosage to be delivered can differ for many factors, though it is limited by appropriate patient restraint, patient positioning, and image guided radiotherapy, all of which were performed in our study to improve accuracy of treatment. 13 Recurrence was not always able to be differentiated from late effects of radiation by use of MRI when initial progression of clinical signs was seen due to owner limitations and allowance of further diagnostic imaging. This was the case for the dog that lived 1272 days. MRI was recommended at the time of return of clinical signs and was declined by the owner until 2.5 years later, at which time MRI documented recurrence and SRT was subsequently performed.
The single dog that had a combination of surgery and SRT for the initial therapy had a much shorter time to progression and survival time when compared with those patients that had surgery alone. This result was not surprising for this particular case due to the extensiveness of the lesion and inability to obtain even a marginal excision at the time of surgery. The intent of surgery was to debulk and obtain a histopathological diagnosis and then treat the residual gross disease with SRT.
One of the meningioma patients in our study was diagnosed with metastatic disease at the time of euthanasia. This patient was also diagnosed with a different neoplasia (mammary) at the time of euthanasia, so metastasis from the meningioma seems less likely, but could not be ruled out. Metastasis of NSTs is rare, but pulmonary metastasis has been reported. 9 No confirmed metastasis from a NST was seen in the patients in this study. Dogs that were euthanized for "other neoplasias" were not censored from survival data because these dogs had survived their spinal tumour post-treatment long enough to develop a second, unrelated neoplasia. Survival times for these dogs were 366, 988 and 555 days, and were some of the longest survival times of the patients in the study.
Weaknesses in this study largely arise from the retrospective nature of the study and the population size. Ideally, the study would include a prospective case acquisition with larger patient numbers, standardized treatment plans, diagnostic evaluation, utilization of a single surgeon and a single pathologist, all with a single variable to determine significance; a research goal that can be increasingly difficult with the nature of a retrospective study, the infrequency of spinal tumours, and the associated challenges in diagnosing and treating spinal tumours. The non-standardized treatment categories, in addition to the varied presence of adjunctive therapies such as chemotherapy and steroid therapy, add several confounding factors when evaluating for survival times. This could be combatted by a larger patient population, allowing for the improved ability to adjust for variables. There is an inherent bias due to lack of power from our population size, leading to potential type II error. The inclusion of patients from more than one hospital was an attempt to combat some of these weaknesses and to obtain a larger patient population.
More cases of spinal tumours need to be treated with SRT to determine the effect and toxicity of this treatment. Outcome and complications of SRT may then be compared with the post-operative recovery, neurologic status, recovery time and time to recurrence for surgery.
In summary, we showed that despite the similar behaviour of meningiomas and NSTs, meningiomas had a significantly longer survival time overall. Our hypothesis was that the addition of radiation therapy modalities to treatment would yield longer times to recurrence of clinical signs and/or longer survival times. Although we showed the additional survival time gained by adding SRT when recurrence was noted, low patient populations within each treatment group was prohibitive to supporting our hypothesis with significant results.
